financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Hold Opinion On Shares Of Reliance, Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Hold Opinion On Shares Of Reliance, Inc.
Apr 26, 2024 1:19 PM

03:45 PM EDT, 04/26/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We decrease our 12-month target by $17 to $313, which assumes an EV/EBITDA of 10.0x our 2024 EBITDA estimate, at the upper end of the three-year range of RS's forward EV/EBITDA (4.5x-11.3x). Our DCF model shows significant upside (40%+) to RS's intrinsic value, but we are concerned about RS's relative valuation, trading at a 40% premium to peers on forward EV/EBITDA. We lower our 2024 EPS estimate by $1.44 to $19.79, but increase our 2024 EPS estimate by $1.89 to $21.08. RS posted Q1 adj. EPS of $5.30 vs. $6.37, $0.21 below consensus; Q1 revenue was down 8% Y/Y and missed consensus by 3%. During Q1, total tons sold fell 1.7% Y/Y (down 2.9% Y/Y organically) and the average selling price per ton fell 6.9% Y/Y to $2,442/ton. We anticipate a rebound in volume, with sequential growth in volume in Q2 of around 3%. We continue to be impressed with RS's resilient gross margin, which was 31.0% in Q1, up 10 basis points Y/Y. However, RS's premium valuation keeps us on the sidelines, as we see limited upside in 2024.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Raises Opinion On Shares Of 10x Genomics Inc. To Hold From Sell
Research Alert: CFRA Raises Opinion On Shares Of 10x Genomics Inc. To Hold From Sell
Jun 26, 2025
11:20 AM EDT, 06/26/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our target price to $12 from $7, based on our DCF analysis, and change our recommendation on shares of TXG to Hold from Sell. We widen our 2025...
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Jefferies Financial Group Inc.
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Jefferies Financial Group Inc.
Jun 26, 2025
01:25 PM EDT, 06/26/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our target by $9 to $66, reflecting near-term challenging market conditions due to U.S. policy and geopolitical events. Our target is based on a P/E of 16.5x our...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Jpmorgan Chase & Co.
Research Alert: CFRA Maintains Hold Opinion On Shares Of Jpmorgan Chase & Co.
Jun 26, 2025
11:05 AM EDT, 06/26/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our target by $25 to $295 using a forward normalized P/E multiple of 15.1x, which is near the five-year historic average at 14.9x, recognizing a wider equity risk...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Micron Corp.
Research Alert: CFRA Maintains Buy Opinion On Shares Of Micron Corp.
Jun 26, 2025
10:20 AM EDT, 06/26/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We up our 12-month target to $155 from $117, on a P/E of 11.5x our CY 2026 EPS view of $13.47, within its 10-year historical range and below peers given...
Copyright 2023-2026 - www.financetom.com All Rights Reserved